Immunotherapy for infectious diseases represents a cutting-edge approach to combatting microbial pathogens by harnessing the body's immune system. Unlike traditional antimicrobial agents, which directly target pathogens, immunotherapy focuses on bolstering the host's immune response to better eliminate invading microbes. This strategy involves various interventions, including vaccines, monoclonal antibodies, and immune modulators, designed to enhance the body's ability to recognize and neutralize infectious agents. For instance, vaccines stimulate the production of pathogen-specific antibodies and memory T-cells, providing long-term protection against future infections. Similarly, monoclonal antibodies can directly target and neutralize microbial toxins or virulence factors, mitigating disease severity. By leveraging the power of immunotherapy, researchers aim to develop novel strategies for preventing and treating a wide range of infectious diseases, potentially revolutionizing the field of infectious disease management.
Title : The role of the humoral innate immune system in evasion of streptococcus pyogenes infections
Francis J. Castellino, University of Notre Dame, United States
Title : Global environmental changes and mosquito-borne diseases in coastal areas
Ranjan Ramasamy, IDFISH Technology, United States
Title : The impact of global antibiotic resistance on the healthcare system, public health, environment and society
Reza Nassiri, Michigan State University, United States
Title : Current topics of adult COVID-19, Influenza, and RS virus patients in Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan
Title : Novel nanotechnology and its potential applications
Stephen Hsu, Augusta University, United States
Title : 2000 years of pandemics: Past, present and future
Claudia Ferreira, Biophytis Sorbonne, France